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Caesarean section surgical techniques (CORONIS): a fractional, 
factorial, unmasked, randomised controlled trial
The CORONIS Collaborative Group*
Summary
Background Variations exist in the surgical techniques used for caesarean section and many have not been rigorously 
assessed in randomised controlled trials. We aimed to assess whether any surgical techniques were associated with 
improved outcomes for women and babies.
Methods CORONIS was a pragmatic international 2×2×2×2×2 non-regular fractional, factorial, unmasked, randomised 
controlled trial that examined ﬁ ve elements of the caesarean section technique in intervention pairs. CORONIS was 
undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan. Each site was assigned to three 
of the ﬁ ve intervention pairs: blunt versus sharp abdominal entry; exteriorisation of the uterus for repair versus intra-
abdominal repair; single-layer versus double-layer closure of the uterus; closure versus non-closure of the peritoneum 
(pelvic and parietal); and chromic catgut versus polyglactin-910 for uterine repair. Pregnant women were eligible if 
they were to undergo their ﬁ rst or second caesarean section through a planned transverse abdominal incision. 
Women were randomly assigned by a secure web-based number allocation system to one intervention from each of 
the three assigned pairs. All investigators, surgeons, and participants were unmasked to treatment allocation.  The 
primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood 
transfusion (>1 unit) up to the 6-week follow-up visit. Women were analysed in the groups into which they were 
allocated. The CORONIS Trial is registered with Current Controlled Trials: ISRCTN31089967.
Findings Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically signiﬁ cant 
diﬀ erences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1·03 (95% CI 
0·91–1·17), exterior versus intra-abdominal repair 0·96 (0·84–1·08), single-layer versus double-layer closure 0·96 
(0·85–1·08), closure versus non-closure 1·06 (0·94–1·20), and chromic catgut versus polyglactin-910 0·90 (0·78–1·04). 
144 serious adverse events were reported, of which 26 were possibly related to the intervention. Most of the reported 
serious adverse events were known complications of surgery or complications of the reasons for the caesarean section.
Interpretation These ﬁ ndings suggest that any of these surgical techniques is acceptable. However, longer-term 
follow-up is needed to assess whether the absence of evidence of short-term eﬀ ects will translate into an absence of 
long-term eﬀ ects.
Funding UK Medical Research Council and WHO.
Introduction
Caesarean section is one of the most commonly under-
taken operations worldwide and accounts for up to 60% 
of deliveries in some countries.1–3 Caesarean section 
carries a risk of short-term postoperative morbidity, for 
example, fever, pain, post-partum haemorrhage, damage 
to the bladder or ureters, and thromboembolic disease. 
Long-term clinical and obstetric problems include 
chronic pain, infertility, bowel obstruction, abnormal 
placen tation and its consequences, and uterine rupture.4–6
Caesarean section is not done in a standardised way, and 
there are variations in the surgical techniques used.7,8 
Many of the surgical techniques have not been rigorously 
assessed in randomised controlled trials and so whether 
any of them are associated with better outcomes for 
women and babies is not known.7 Because large numbers 
of women undergo caesarean section, even small diﬀ er-
ences in postoperative morbidity between techniques 
could mean improved health for a large number of women 
and substantial savings for health services. Rigorous 
random ised controlled trials are needed to establish the 
eﬀ ective ness of diﬀ erent surgical techniques. We therefore 
undertook the present trial to assess whether ﬁ ve speciﬁ c 
approaches to the surgical techniques were associated 
with improved outcomes for women and babies.
Methods
Study design and participants
After widespread interest from many countries to 
participate in the UK trial of caesarean section surgical 
techniques (CAESAR),9 WHO funded a workshop in 
Oxford, UK, to develop a proposal for a new trial to be 
undertaken in these countries. At this workshop, 
investigators reviewed all the available evidence for each 
element of the caesarean section operation and produced, 
through a formal consensus process, a ranked list of 
candidate intervention pairs to include in the trial. 
Eligibility for inclusion as a trial intervention was based 
on a range of criteria including the clinical importance of 
resolving the uncertainty for short-term and long-term 
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outcomes, the quality and quantity of available evidence, 
and the feasibility of undertaking the interventions in the 
participating countries.
Based on the ﬁ ndings from the workshop, we under-
took a multicentre, unmasked, randomised controlled 
trial at 19 sites in Argentina, Chile, Ghana, India, Kenya, 
Pakistan, and Sudan to assess two surgical techniques 
(intervention pairs) for ﬁ ve elements of the caesarean 
section operation. The ﬁ ve intervention pairs were as 
follows: (1) blunt versus sharp abdominal entry; (2) 
exteriorisation of the uterus for repair versus intra-
abdominal repair; (3) single-layer versus double-layer 
closure of the uterus; (4) closure versus non-closure of 
the peritoneum (pelvic and parietal); and (5) chromic 
catgut versus polyglactin-910 for uterine repair. The 
methods have been summarised previously.10
Pregnant women were eligible if they were to undergo 
delivery by lower segment caesarean section through 
a transverse abdominal incision, irrespective of fever in 
labour, gestational age, or multiple pregnancies. Women 
were not eligible if there was a clear indication for a 
particular surgical technique or material to be used that 
prevented any of the allocated interventions being used, 
if they had more than one previous caesarean section, or 
if they had already been recruited into the trial.
The National Perinatal Epidemiology Unit Clinical 
Trials Unit (Oxford, UK) and each participating site 
secured approval from their research ethics committee 
or equivalent body. The trial was overseen by an 
independent trial steering commit tee. An independent 
data monitoring com mit tee monitored eﬀ ectiveness and 
safety annually. The data monitoring committee used the 
Haybittle–Peto11,12 approach for interim analyses using 
three standard errors as the cutoﬀ  for consideration of 
early cessation, preserving the type-one error rate across 
the trial.
Each participating site, advised by their research 
ethics committee, decided how to provide trial 
information to women and seek informed consent. 
Information leaﬂ ets were made available, in appropriate 
languages, which explained the trial objectives, the 
process of trial entry, and follow-up. The trial was 
discussed with all eligible women and their partners 
and relatives as appropriate. If the woman agreed to 
participate, she signed a formal consent form or used 
the method of recording consent permitted in that 
setting (eg, a thumb print).
Randomisation and masking
Although there were ﬁ ve intervention pairs, each site was 
assigned only three to maximise compliance (appendix), 
thereby making this a 2×2×2×2×2 fractional, factorial trial 
(more correctly termed a non-regular fractional, factorial 
trial).13 Women were randomly allocated to one inter-
vention from each of the three assigned pairs. Random-
isation was done using a bespoke secure web-based 
system, with a 24-h automated telephone back-up. 
The system allocated a number corresponding to a 
unique allocation envelope held at participating sites. 
The allocation numbers were generated by computer 
implementation of a pseudo-random generating algo-
rithm. Each envelope contained an allocation sheet 
detailing the three allocated interventions for a woman, 
as a reminder to the surgeon. In instances where there 
was no internet or telephone connectivity, the recruiting 
clinician selected the lowest sequentially numbered 
allocation envelope. All randomisation data were held 
centrally at the international coordinating centre (National 
Perinatal Epidemiology Unit Clinical Trials Unit).
We used minimisation to ensure balance within sites, 
within and between intervention pairs, and with respect to 
in-labour and not in-labour caesarean section and ﬁ rst or 
second caesarean section. For sites where chromic catgut 
versus polyglactin-910 was one of the assigned intervention 
pairs, supplies of both suture materials were provided by 
the international coordinating centre and were contained 
in a speciﬁ c trial box stored in the operating theatre.
All investigators, surgeons, and participants were un-
masked to treatment allocation.
Procedures
Each regional coordinator (one per country, except India, 
which was split into two regions) started and documented 
a train ing programme that ensured that surgeons 
operating within the trial were familiar with the tech-
niques being compared before participating. To facilitate 
this, the international coordinating centre gave a DVD of 
the interventions tested to all study sites.
The procedures for blunt versus sharp abdominal 
entry were as follows. For sharp entry, the abdomen was 
entered using a scalpel to divide the abdominal skin. 
Each subsequent layer of the abdomen was then 
separately identiﬁ ed and divided using either a scalpel or 
scissors. In blunt entry, the abdomen was entered using 
a scalpel to divide the abdominal skin. The scalpel was 
then used to divide the fat and rectus sheath in the 
midline and the rectus sheath incision extended 
manually. The parietal peritoneum was then entered 
digitally and the defect enlarged manually.
For exteriorisation of the uterus for repair versus intra-
abdominal repair, once the placenta had been delivered, 
either the uterus was drawn from the pelvis to rest on the 
anterior abdominal wall so that the uterine incision could 
clearly be visualised or the uterus was repaired while in 
the pelvis.
For the comparison of single-layer versus double-layer 
closure of the uterus, the uterine incision was closed 
with either one or two layers of sutures. Each layer could 
be closed using any accepted technique. Haemostasis 
of the incision could be done with additional sutures as 
judged necessary by the surgeon regardless of the 
method of closure undertaken.
For closure versus non-closure, the pelvic and parietal 
peritoneum was either closed or not closed. For either 
See Online for appendix
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technique, haemostasis was achieved as usual, including, 
where necessary, the use of haemostatic sutures.
Finally, for chromic catgut versus polyglactin-910 for 
uterine repair, the uterus was repaired using either 
number 1 chromic catgut (Medsurge, Philadelphia, PA, 
USA) or number 1 polyglactin-910 (Ethicon, Livingston, 
NJ, UK). This could be a continuous, continuous locking, 
or an inter rupted layer of sutures. For sites where 
chromic catgut versus polyglactin-910 was one of the 
assigned intervention pairs, surgeons were asked to 
restrict their use of the allocated suture material to repair 
of the uterine incision and to use their usual suture 
material for all other layers.
All non-allocated surgical elements and all other 
aspects of the caesarean section procedure were 
undertaken at the discretion of the surgeon. In particular, 
there were no restrictions on the type of suture material 
that could be used, and standard measures to achieve 
haemostasis were employed regardless of the allocated 
intervention.
The primary outcome was a composite of death, 
maternal infectious morbidity, further operative pro-
cedures, or blood transfusion of more than 1 unit of 
whole blood or packed cells up to the 6-week follow-up 
visit. Maternal infectious morbidity was deﬁ ned as one or 
more of the following: antibiotic use for maternal febrile 
morbidity during postnatal hospital stay or for endo-
metritis, wound infection, or peritonitis up to the 6-week 
follow-up visit. Blood transfusion as part of the composite 
primary outcome was changed on June 14, 2010, from 
any blood transfusion to transfusion of more than 1 unit 
of blood when the data monitoring committee and 
international coordinating centre became aware that one 
site was transfusing 1 unit of blood routinely.
Secondary outcomes consisted of the individual 
components of the primary outcome as well as pain, 
Figure 1: Trial proﬁ le
N/A=not applicable. *Consisted of power outages and shortage of equipment. †Included in the primary analysis. ‡Ascertained after randomisation. §Randomised twice because the woman had a previous 
caesarean section in the CORONIS trial. ¶Two were going to have a hysterotomy, one a colpotomy, one was a uterine rupture known before trial entry, and one had a rudimentary horn pregnancy.
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interventions used for severe primary post-partum 
haemorrhage, stillbirth after trial entry, other severe 
maternal morbidity, Apgar score less than 3 at 5 min, 
laceration of baby at time of caesarean section, and death 
of the baby by 6 weeks of age. Secondary health service 
utilisation outcomes consisted of the duration of the 
operation, duration of hospital stay, admission to 
intensive care and duration of stay, and readmission to 
hospital within 6 weeks and duration of stay.
Data were collected at trial entry, immediately after 
surgery, at hospital discharge (including hospital 
transfer or death), and at about 6 weeks after delivery. 
Women who did not return at 6 weeks were located and 
interviewed by telephone or during a home visit. 
Serious adverse events were assessed by the chief 
investigator and data monitoring committee as soon as 
they were reported to the international coordinating 
centre.
Abdominal entry Repair of uterus Closure of uterus Closure of peritoneum Uterine repair sutures Total (n=15 729)
Blunt 
(n=4619)
Sharp 
(n=4628)
Exterior 
(n=4899)
Intra-abdominal 
(n=4896)
Single 
(n=4639)
Double 
(n=4647)
Closure 
(n=4824)
Non-closure 
(n=4851)
Catgut 
(n=4594)
PG-910 
(n=4590)
Region
Argentina 809 (17%) 808 (17%) 807 (16%) 810 (16%) N/A* N/A* 808 (17%) 809 (17%) N/A* N/A* 1617 (10%)
Chile N/A* N/A* 607 (12%) 598 (12%) 353 (8%) 347 (8%) 597 (12%) 608 (13%) 254 (6%) 251 (5%) 1205 (8%)
Ghana 631 (14%) 639 (14%) N/A* N/A* 634 (14%) 636 (14%) N/A* N/A* 637 (14%) 633 (14%) 1270 (8%)
India: Delhi 1327 (29%) 1330 (29%) 1082 (22%) 1081 (22%) 1875 (41%) 1882 (41%) 1347 (28%) 1347 (28%) N/A* N/A* 3757 (24%)
India: Vellore† 790 (17%) 785 (17%) 263 (5%) 263 (5%) N/A* N/A* 1047 (22%) 1054 (22%) 1050 (23%) 1051 (23%) 2101 (13%)
Kenya 829 (18%) 828 (18%) 831 (17%) 826 (17%) N/A* N/A* N/A* N/A* 830 (18%) 827 (18%) 1657 (11%)
Pakistan† 233 (5%) 238 (5%) 514 (10%) 520 (11%) 981 (21%) 985 (21%) 1025 (21%) 1033 (21%) 1029 (22%) 1029 (22%) 2529 (16%)
Sudan N/A* N/A* 795 (16%) 798 (16%) 796 (17%) 797 (17%) N/A* N/A* 794 (17%) 799 (17%) 1593 (10%)
Maternal characteristics at trial entry
Mother’s age (years) 26·5 (5·3) 26·7 (5·3) 27·1 (5·7) 27·1 (5·7) 26·9 (5·4) 26·8 (5·4) 26·4 (5·2) 26·5 (5·3) 28·0 (5·4) 28·0 (5·4) 27·0 (5·4)
Nulliparous‡ 2385 (52%) 2352 (51%) 2186 (45%) 2249 (46%) 2160 (47%) 2248 (48%) 2282 (47%) 2332 (48%) 1976 (43%) 1985 (43%) 7385 (47%)
Previous caesarean section 
None 3351 (73%) 3361 (73%) 3265 (67%) 3266 (67%) 3182 (69%) 3183 (69%) 3113 (65%) 3119 (64%) 2919 (64%) 2927 (64%) 10 562 (67%)
One 1268 (27%) 1267 (27%) 1634 (33%) 1630 (33%) 1457 (31%) 1464 (31%) 1711 (35%) 1732 (36%) 1675 (36%) 1663 (36%) 5167 (33%)
Previous caesarean section incision
Abdominal 
transverse
1213 (96%) 1214 (96%) 1591 (97%) 1595 (98%) 1421 (98%) 1426 (97%) 1652 (97%) 1672 (97%) 1612 (96%) 1601 (96%) 4999 (97%)
Uterine 
transverse
1180 (93%) 1189 (94%) 1443 (88%) 1430 (88%) 1273 (87%) 1288 (88%) 1560 (91%) 1577 (91%) 1585 (95%) 1584 (95%) 4703 (91%)
Uterine unknown 83 (7%) 75 (6%) 185 (11%) 192 (12%) 178 (12%) 171 (12%) 146 (9%) 148 (9%) 86 (5%) 74 (4%) 446 (9%)
Operation and delivery details
Caesarean section undertaken
Before start of 
labour 
2227 (48%) 2238 (48%) 2848 (58%) 2846 (58%) 2543 (55%) 2570 (55%) 2677 (55%) 2694 (56%) 2797 (61%) 2789 (61%) 8743 (56%)
After start of 
labour
2392 (52%) 2390 (52%) 2051 (42%) 2050 (42%) 2096 (45%) 2077 (45%) 2147 (45%) 2157 (44%) 1797 (39%) 1801 (39%) 6986 (44%)
Main indication for caesarean section
Fetal 
compromise
1167 (25%) 1160 (25%) 966 (20%) 988 (20%) 1033 (22%) 1053 (23%) 1099 (23%) 1110 (23%) 872 (19%) 833 (18%) 3427 (22%) 
Failure to 
progress
988 (21%) 981 (21%) 995 (20%) 944 (19%) 1096 (24%) 1074 (23%) 1089 (23%) 1082 (22%) 1041 (23%) 1042 (23%) 3444 (22%)
Obstetric 
complications
1572 (34%) 1573 (34%) 1614 (33%) 1662 (34%) 1653 (36%) 1647 (35%) 1460 (30%) 1497 (31%) 1431 (31%) 1470 (32%) 5193 (33%)
Maternal request 201 (4%) 178 (4%) 241 (5%) 201 (4%) 98 (2%) 103 (2%) 265 (6%) 273 (6%) 302 (7%) 310 (7%) 724 (5%)
Previous 
caesarean section
306 (7%) 331 (7%) 477 (10%) 479 (10%) 250 (5%) 259 (6%) 546 (11%) 517 (11%) 290 (6%) 286 (6%) 1247 (8%)
Other 385 (8%) 405 (8%) 606 (12%) 622 (13%) 509 (11%) 511 (11%) 365 (8%) 372 (8%) 658 (14%) 649 (14%) 1694 (11%)
Data are number (%) or mean (SD), unless otherwise stated. Missing data are <1% unless otherwise presented. Some percentages do not total 100 because of rounding. Excludes women randomised in error, women 
who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). Additional baseline characteristics are detailed in the appendix. N/A=not applicable. PG-910=polyglactin-910. *Intervention pairs not 
assigned in these regions. †Some sites within these regions switched intervention pairs. ‡Women with no previous births. A previous birth is deﬁ ned as a live or stillbirth of estimated gestational age >24 weeks (or 
>28 weeks depending on country-speciﬁ c deﬁ nitions), regardless of previous mode of delivery or multiple pregnancy (multiple pregnancy counts as one birth). 
Table 1: Demographics and key baseline characteristics
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Statistical analysis
A sample size of 15 000 women was needed, with at least 
9000 women in each intervention pair, to have at least 
80% power to detect a 15% relative risk reduction in the 
primary outcome from a baseline incidence of 15% 
(estimated from a pilot study of 855 consecutive women 
who were to undergo a caesarean section [Brocklehurst P, 
unpublished]), assuming 15% loss to follow-up.
A detailed statistical analysis plan was developed and 
approved by the trial steering committee (appendix). For 
the analysis of maternal outcomes, women were 
analysed in the groups into which they were allocated; 
for example, comparing women allocated to blunt 
abdominal entry with those allocated to sharp abdominal 
entry, regardless of what interventions they actually 
received. For the analysis of neonatal outcomes, 
neonates were analysed according to the groups 
allocated to the women. Neonatal outcomes were only 
analysed in the intervention pair blunt versus sharp 
abdominal entry because these were the only 
interventions that could have an eﬀ ect on neonatal 
outcomes. In the analysis of neonatal outcomes, 
neonates from multiple births were treated as 
independent, but the eﬀ ect of adjusting for potential 
clustering was also assessed.14
The focus of the primary analysis was the main eﬀ ects 
of the ﬁ ve intervention pairs analysed separately. Pairwise 
interactions were planned if the analyses showed any 
statistically signiﬁ cant main eﬀ ects for the primary 
outcome only. Subgroup analyses according to caesarean 
Abdominal entry Repair of uterus Closure of uterus Closure of peritoneum Uterine repair sutures Total 
(n=15 729)
Blunt 
(n=4619)
Sharp 
(n=4628)
RR (CI) Exterior 
(n=4899)
Intra-
abdominal 
(n=4896)
RR (CI) Single 
(n=4639)
Double 
(n=4647)
RR (CI) Closure 
(n=4824)
Non-
closure 
(n=4851)
RR (CI) Catgut 
(n=4594)
PG-910 
(n=4590)
RR (CI) 
Primary outcome*
Number 
(%) 
439
(10%)
428
(9%)
1·03 
(0·91–
1·17)
434
(9%)
454
(9%)
0·96 
(0·84–
1·08)
479
(10%)
499
(11%)
0·96 
(0·85–
1·08)
496
(10%)
469
(10%)
1·06 
(0·94–
1·20)
334
(7%)
369
(8%)
0·90 
(0·78–
1·04)
1467
(9%)
Death
Number 
(%)
6
(0·1%)
8
(0·2%)
0·75 
(0·19–
3·02)
1
(<0·1%)
4
(0·1%)
0·25 
(0·01–
4·45)
8
(0·2%)
5
(0·1%)
1·60 
(0·37–
6·95)
2
(<0·1%)
3
(0·1%)
0·67 
(0·06–
7·04)
5
(0·1%)
6
(0·1%)
0·83 
(0·18–
3·96)
16
(0·1%)
Antibiotics for febrile morbidity†
Number 
(%)
91
(2%)
81
(2%)
1·13 
(0·76–
1·66)
52
(1%)
49
(1%)
1·06 
(0·64–
1·77)
47
(1%)
47
(1%)
1·00 
(0·59–
1·70)
100
(2%)
84
(2%)
1·20 
(0·82–
1·75)
52
(1%)
69
(2%)
0·75 
(0·47–
1·20)
224
(1%)
Antibiotics for endometritis
Number 
(%)
46
(1%)
36
(1%)
1·28 
(0·72–
2·27)
43
(1%)
43
(1%)
1·00 
(0·57–
1·74)
38
(1%)
34
(1%)
1·12 
(0·61–
2·05)
53
(1%)
56
(1%)
0·95 
(0·58–
1·56)
43
(1%)
52
(1%)
0·83 
(0·49–
1·40)
148 
(1%) 
Antibiotics for wound infection
Number 
(%)
313
(7%)
276
(6%)
1·14 
(0·93–
1·40)
302
(6%)
324
(7%)
0·93 
(0·76–
1·14)
353
(8%)
379
(8%)
0·93 
(0·78–
1·12)
330
(7%)
310
(6%)
1·07 
(0·88–
1·30)
218
(5%)
204
(5%)
1·07 
(0·84–
1·36)
1003
(6%)
Antibiotics for peritonitis
Number 
(%)
1
(<0·1%) 
3
(0·1%)
0·33 
(0·02–
6·54) 
1
(<0·1%)
0
(0%)
·· 0
(0%)
1
(<0·1%)
·· 4
(0·1%)
1
(<0·1%)
4·02 
(0·23–
71·6)
1
(<0·1%)
3
(0·1%)
0·33 
(0·02–
6·52)
5
(<0·1%)
Any further operative procedures‡
Number 
(%)
95
(2%)
91
(2%)
1·05 
(0·72–
1·52)
82
(2%)
79
(2%)
1·04 
(0·69–
1·55)
74
(2%)
87
(2%)
0·85 
(0·57–
1·28)
80
(2%)
67
(1%)
1·20 
(0·79–
1·83)
33
(1%)
53
(1%)
0·62 
(0·35–
1·10)
247 
(2%)
Blood transfusion§
Number 
(%)
40
(1·0%)
56
(1·2%)
0·72 
(0·42–
1·22)
75
(1·5%)
72
(1·5%)
1·04 
(0·68–
1·59)
76
(1·6%)
79
(1·7%)
0·96 
(0·64–
1·45)
63
(1·3%)
62
(1·3%)
1·02 
(0·65–
1·62)
32
(0·7%)
60
(1·3%)
0·53 
(0·30–
0·93)
205
(1·3%)
Missing data are <1% unless otherwise presented. Excludes women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). CI values are 95% for primary 
outcome and 99% for all others. PG-910=polyglactin-910. RR=risk ratio. *A woman may have more than one component but is included only once in the primary outcome. Primary outcome deﬁ ned as death or 
maternal infectious morbidity or further operative procedures or blood transfusion (>1 unit of whole blood and packed cells only). †Maternal infectious morbidity deﬁ ned as one or more of the following: 
antibiotic use for maternal febrile morbidity during post-partum stay (fever on at least two occasions); antibiotic use for endometritis, wound infection, or peritonitis up to 6 weeks post partum. ‡Includes any 
operative procedures on caesarean wound, curettage, laparotomy, artery ligation, brace suture, and hysterectomy. §>1 unit of whole blood and packed cells only.
Table 2: Primary outcome and its components
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Abdominal entry Repair of uterus Closure of uterus Closure of peritoneum Uterine repair sutures Total
(n=15 729)
Blunt
(n=
4619)
Sharp
(n=
4628)
RR or MD 
(99%CI)
Exterior 
(n= 
4899)
Intra-
abdom-
inal (n= 
4896)
RR or MD 
(99% CI)
Single
(n=
4639)
Double
(n=
4647)
RR or MD 
(99% CI)
Closure
(n=
4824)
Non-
closure 
(n=
4851)
RR or MD 
(99% CI)
Catgut
(n=
4594)
PG-910 
(n=
4590)
RR or MD 
(99% CI)
Further operative procedures on wound*
Number (%) 60
(1%)
38
(1%)
RR 1·58 
(0·93 
to 2·69)
35
(1%)
36
(1%)
RR 0·97 
(0·53 
to 1·79)
30
(1%)
38
(1%)
RR 0·79 
(0·42 
to 1·48)
48
(1%)
44
(1%)
RR 1·10 
(0·64 
to 1·87)
20
(<1%)
29
(1%)
RR 0·69 
(0·33 to 
1·45)
126
(1%)
Additional analgesia given 24–48 h after caesarean section
Number (%) 316
(7%)
311
(7%)
RR 1·02 
(0·83 
to 1·24)
204
(4%)
188
(4%)
RR 1·08 
(0·84 
to 1·40)
203
(4%)
185
(4%)
RR 1·10 
(0·85 
to 1·42)
250
(5%)
236
(5%)
RR 1·06 
(0·85 
to 1·34)
159
(4%)
171
(4%)
RR 0·93 
(0·70 
to 1·23)
741
(5%)
Pain at 6 weeks’ follow-up
Continual 
(number [%])
62
(1%)
53
(1%)
RR 1·17 
(0·73 
to 1·89)
97
(2%)
99
(2%)
RR 0·98 
(0·68 
to 1·41)
85
(2%)
83
(2%)
RR 1·03 
(0·69 
to 1·53)
103
(2%)
108
(2%)
RR 0·96 
(0·67 
to 1·36)
81
(2%)
63
(1%)
·· 278
(2%)
Data missing 
(number [%])
109
(2%)
107
(2%)
·· 86
(2%)
93
(2%)
·· 98
(2%)
81
(2%)
·· 103
(2%)
107
(2%)
·· 43
(1%)
40
(1%)
RR 1·29 
(0·84 
to 1·97)
289
(2%)
Interventions used for post-partum haemorrhage†
Number (%) 48
(1%)
58
(1%)
RR 0·83 
(0·50 
to 1·37)
76
(2%)
76
(2%)
RR 1·00 
(0·66 
to 1·51)
49
(1%)
52
(1%)
RR 0·94 
(0·57 
to 1·57)
71
(2%)
71
(2%)
RR 1·01 
(0·65 
to 1·54)
15
(<1%)
30
(1%)
RR 0·50 
(0·22 
to 1·13)
182
(1%)
Any other severe maternal morbidity‡
Number (%) 11
(<1%)
8
(<1%)
RR 1·38 
(0·42 
to 4·56) 
8
(<1%)
12
(<1%)
RR 0·67 
(0·21 
to 2·16)
12
(<1%)
16
(<1%)
RR 0·75 
(0·28 
to 2·01) 
24
(<1%)
12
(<1%)
RR 2·01 
(0·81 
to 4·99)
18
(<1%)
20
(<1%)
RR 0·90 
(0·39 
to 2·07)
47
(<1%)
Duration of operation (min from incision to closure)
Median (IQR) 40
(30–
48)
40
(30–
50)
MD 0 
(0 to 0)
40
(30–
50)
40
(30–
50)
MD 0 
(0 to 0)
40
(30–
47)
40
(30–
50)
MD 0 
(0 to 0)
40
(30–
50)
40
(30–
50)
MD 0 
(0 to 0)
35
(30–
45)
35
(30
–45)
MD 0 
(0 to 0)
40 
(30–
46)
Duration of hospital stay after caesarean section (days)§
Median (IQR) 4 
(4–6)
4
(4–6)
MD 0 
(0 to 0)
4 
(4–5)
4 
(3–5)
MD 0 
(0 to 0)
4
(4–6)
4
(4–6)
MD 0 
(0 to 0)
4
(4–5)
4
(4–5)
MD 0 
(0 to 0)
4
(4–5)
4
(4–5)
MD 0 
(0 to 0)
4
(4–5)
ICU stay
Women admitted to ICU¶
Number (%) 19
(<1%)
15
(<1%)
·· 30
(1%)
14
(<1%)
·· 23
(1%)
17
(<1%)
·· 18
(<1%)
28
(1%)
·· 11
(<1%)
20
(<1%)
·· 65
(<1%)
Duration of stay in ICU after caesarean section (days)¶
Median (IQR) 3·5
(2–8) 
2
(2–4)
MD 1 
(0 to 3)
3
(2–4)
2·5
(2–4)
MD 0 
(–1 to 1)
3
(2–4)
3
(2–4)
MD 0 
(–1 to 1)
2
(2–4)
3
(2–4)
MD 0 
(–1 to 1)
3
(3–4)
2 
(2–5)
MD 1 
(0 to 2)
3
(2–4)
Readmission to hospital within 6 weeks of caesarean section 
Number 
readmitted 
(%)
43
(1%)
36
(1%)
RR 1·20 
(0·67 
to 2·14)
37
(1%)
43
(1%)
RR 0·86 
(0·48 
to 1·53)
37
(1%)
33
(1%)
RR 1·13 
(0·61 
to 2·08)
47
(1%)
47
(1%)
RR 1·00 
(0·59 
to 1·71)
27
(1%)
25
(1%)
RR 1·08 
(0·53 
to 2·20)
125
(1%)
Data missing 
(%)
109
(2%)
107
(2%)
·· 86
(2%)
93
(2%)
·· 98
(2%)
81
(2%)
·· 103
(2%)
107
(2%)
·· 43
(1%)
40
(1%)
·· 289
(2%)
Duration of stay for readmissions (days)||
Median (IQR) 7
(4–11)
5
(4–9)
MD 1 
(–1 to 3)
6
(3–9)
7
(4–10)
MD –1 
(–3 to 1)
6
(3–9)
6
(4–9)
MD –1 
(–3 to 1)
6
(4–9)
5
(3–9)
MD –1 
(–1 to 2)
6
(4–10)
5
(3–6)
MD 1 
(0 to 4)
6
(4–9)
Missing data are <1% unless otherwise presented. Excludes women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). ICU=intensive care unit. 
MD=median diﬀ erence. PG-910=polyglactin-910. RR=risk ratio. *Includes any procedures on the wound because of infection, dehiscence, or haematoma. †Includes additional uterotonics, balloon tamponade, 
brace suture, artery ligation, and hysterectomy. ‡Includes at least one of the following: antibiotics for peritonitis (n=5), antibiotics for sepsis (n=8), antibiotics for infection (n=3), post-partum haemorrhage 
(n=24), deep-vein thrombosis (n=7), pulmonary embolism (n=0), or septic shock (n=2). §Women in some centres were kept in for rest or to wait for the baby to be discharged. ¶In some sites, women were 
admitted to the ICU routinely; these women have been excluded from this analysis. ||If admission date and discharge date were the same, the length of stay was regarded as 1 day. Six women had two 
re-admissions; their lengths of stay have been summed. 
Table 3: Secondary outcomes
Articles
240 www.thelancet.com   Vol 382   July 20, 2013
section in or not in labour, multiple or singleton birth, 
number of previous caesarean sections, type of 
anaesthetic, experience of surgeon, and country were 
prespeciﬁ ed in the protocol.10
The risk ratio for every outcome was calculated for 
each intervention pair. For the primary outcome, 
95% CIs are presented for each comparison. For 
secondary outcomes, 99% CIs are presented to take 
account of the number of comparisons. Subgroup 
analyses are presented as forest plots along with results 
of Mantel–Haenszel χ² tests for interaction. A p value of 
less than 0·05 was deemed statistically signiﬁ cant for 
Abdominal entry Risk ratio (99% CI) OR (99% CI)* Accounting for multiple 
births, OR (99% CI)†
Total neonates 
(n=9638)
Blunt Sharp
Stillbirth‡ 54/4801 (1·1%) 43/4837 (0·9%) 1·27 (0·75–2·14%) 1·27 (0·75–2·15%) 1·27 (0·74–2·18%) 97/9638 (1·0%)
Apgar score ≤3 at 5 min 19/4737 (0·4%) 17/4792 (0·4%) 1·13 (0·48–2·67%) 1·13 (0·48–2·68%) 1·13 (0·48–2·68%) 36/9541 (0·4%)
Laceration of baby at time of caesarean section 3/4747 (0·1%) 2/4794 (<0·1%) 1·51 (0·14–15·9%) 1·26 (0·22–7·10%) 1·26 (0·22–7·10%) 5/9541 (0·1%)
Death of baby by 6 weeks of age§ 104/4638 (2·2%) 88/4685 (1·9%) 1·19 (0·83–1·73%) 1·20 (0·82–1·75%) 1·20 (0·82–1·75%) 192/9323 (2·1%)
Stillbirth or death of baby by 6 weeks of age 158/4692 (3·4%) 131/4728 (2·8%) 1·22 (0·90–1·64%) 1·22 (0·90–1·67%) 1·22 (0·90–1·67%) 289/9323 (3·1%)
Data missing at 6 weeks 109/4692 (2·4%) 109/4728 (2·3%) ·· ·· ·· 218/9323 (2·3%)
Data are number (%) unless otherwise stated. Excludes babies born to women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). OR=odds ratio. 
*ORs are presented because the adjustment to account for multiple births cannot be calculated for risk ratios. †17 stillbirths were from a multiple pregnancy (16 twins [ten blunt, six sharp] and one triplet 
[blunt]). Twins from two women (one blunt, one sharp) were recorded as both sets stillborn. ‡Because of the correlation of outcomes within babies from multiple births, standard errors were estimated using a 
clustered sandwich estimator. §Excludes stillbirths.
Table 4: Neonatal outcomes
Figure 2: Abdominal entry subgroup analyses
RR=risk ratio.
Timing of caesarean section
Before labour
In labour
Births
Multiple
Singleton
Previous caesarean sections
None
One
Type of anaesthetic 
Regional
General
Surgeons’ experience
<5 years
5–10 years
>10 years
Region
Argentina
Ghana
India: Delhi
India: Vellore
Kenya
Pakistan 
Favours blunt entry Favours sharp entry
1·000·750·50 1·50 2·000·25 3·00
0·05
0·91
0·46
0·09
0·81
0·05
pinteraction
0·92 (0·73–1·14)
1·19 (0·92–1·53)
1·06 (0·52–2·16)
1·03 (0·87–1·22)
1·06 (0·87–1·28)
0·94 (0·67–1·32)
1·08 (0·90–1·29)
0·79 (0·51–1·22)
1·00 (0·75–1·33)
1·09 (0·84–1·41)
1·00 (0·70–1·43)
1·62 (1·06–2·47)
0·94 (0·55–1·62)
1·00 (0·76–1·33)
1·01 (0·66–1·55)
0·78 (0·48–1·25)
0·88 (0·54–1·42)
RR (99% CI)
230/2391
209/2226
22/178
417/4439
335/3349
104/1268
383/4002
56/615
148/1819
195/1951
93/825
89/808
41/631
150/1326
67/790
49/829
43/233
Events (blunt)
251/2390
177/2238
24/206
404/4422
318/3361
110/1267
357/4015
71/613
150/1836
176/1918
94/838
55/808
44/639
150/1330
66/785
63/828
50/238
Events (sharp)
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the primary outcome and less than 0·01 for all secondary 
outcomes and subgroup analyses.
An adjusted analysis was prespeciﬁ ed for the primary 
outcome to investigate the eﬀ ect of minimisation factors: 
in-labour versus not in-labour caesarean section and 
number of previous caesarean sections. Several 
sensitivity analyses of the primary outcome were also 
prespeciﬁ ed in the analysis plan. All analyses were 
undertaken using Stata/SE (version 11.2).
The CORONIS trial is registered with Current 
Controlled Trials, ISRCTN31089967.
Role of the funding source
The trial was funded by the UK Medical Research Council. 
WHO contributed to the cost of the initial protocol 
development meeting and site set-up costs in the ﬁ rst 
year. The sponsors of the study had no role in study 
design, data collection, data analysis, data interpretation, 
or writing of the report. The corresponding author had 
full access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Between May 20, 2007, and Dec 31, 2010, 15 935 women 
were recruited at 19 sites in Argentina, Chile, Ghana, 
India, Kenya, Pakistan, and Sudan (appendix). The 
appendix describes the character istics of the participating 
countries and sites.
After the second meeting of the data monitoring 
committee on July 22, 2009, when data from 7972 women 
were reviewed, the data monitoring committee informed 
the trial steering committee that, instead of an expected 
primary outcome incidence of around 15%, the incidence 
was 4·7%. The investigators assessed this discrepancy, 
masked to treatment allo cation, and found that the 
overall incidence of the primary outcome varied sub-
stantially between sites and consequently an extensive 
validation exercise was undertaken between Aug 13, 
2009, and March 3, 2011 (appendix). Validation was done 
by independent observers and included reviewing source 
records and interviewing participating women. This 
exercise resulted in an overall primary outcome 
incidence of 9·3%. After considering many scenarios, 
Figure 3: Repair of uterus subgroup analyses
RR=risk ratio.
Timing of caesarean section
Before labour
In labour
Births
Multiple
Singleton
Previous caesarean sections
None
One
Type of anaesthetic 
Regional
General
Surgeons’ experience
<5 years
5–10 years
>10 years
Region
Argentina
India: Delhi
India: Vellore
Kenya
Pakistan
Chile
Sudan 
Favours exterior Favours intra-abdominal
pinteractionRR (99% CI)Events (exterior) Events (intra-abdominal)
1·02 (0·80–1·29)
0·90 (0·71–1·13)
1·17 (0·55–2·49)
0·95 (0·80–1·12)
0·93 (0·77–1·13)
1·01 (0·75–1·38)
0·93 (0·78–1·11)
1·14 (0·69–1·88)
1·33 (0·96–1·82)
0·89 (0·68–1·17)
0·78 (0·59–1·04)
0·92 (0·61–1·39)
1·01 (0·75–1·37)
0·83 (0·39–1·76)
1·28 (0·80–2·05)
0·69 (0·44–1·08)
1·05 (0·69–1·59)
0·82 (0·45–1·50)
216/2051
218/2848
21/167
413/4732
303/3265
131/1634
381/4412
53/487
140/1472
153/1651
137/1750
69/807
131/1082
20/263
63/831
50/514
69/607
32/795
212/2049
242/2846
20/186
434/4709
325/3265
129/1630
410/4434
44/461
105/1464
176/1698
171/1709
75/809
129/1081
24/263
49/826
73/520
65/598
39/798
0·34
0·48
0·56
0·33
0·005
0·30
1·000·750·50 1·50 2·000·25 3·00
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the trial steering committee recommended continuation 
of recruitment until the end of 2010 (4 months later than 
planned), when about 16 000 women would have been 
enrolled. This would still give 80% power to detect a 
relative risk reduction of 0·825 if the overall primary 
outcome incidence was at least 9·0%. To ensure at least 
9000 women were included in each intervention pair, 
close monitoring of recruitment was done weekly by the 
international coordinating centre. This led to three sites 
switching intervention pairs in 2010 (appendix).
In accordance with the prespeciﬁ ed analysis plan, 
206 (1·3%) of the 15 935 women were excluded from the 
analysis, of whom 143 (0·9%) had a vaginal delivery 
(ﬁ gure 1). These women were evenly distributed among 
the intervention pairs and were excluded from the 
analysis because they were not at risk of wound-related 
problems. Trial entry and discharge data were available 
for 15 913 (99·9%) of 15 935 women and 6-week data for 
15 611 (98·0%) women (ﬁ gure 1). Compliance with all 
the allocated interventions was high, 87% overall 
(ﬁ gure 1). The diﬀ erence in compliance between single 
and double layer closure of the uterus (83% vs 98%, 
respectively) was mostly explained by clinical decisions 
during surgery.
Baseline characteristics were similar within and across 
inter vention pairs (table 1; appendix). The mean age was 
27·0 years (SD 5·4), almost half were nulliparous, about 
a third were undergoing a second caesarean section, just 
over half underwent caesarean section before the start of 
labour, and 15% were less than 37 weeks gestation. 
99% of women received prophylactic antibiotics and 
prophylactic uterotonics and 7% received prophylactic 
heparin (appendix).
The incidence of the primary outcome was 9·3% 
overall and varied from 7·3% to 10·7% by intervention 
pair (table 2). There were no statistically signiﬁ cant 
diﬀ erences within any of the intervention pairs for the 
primary outcome (table 2). As prespeciﬁ ed in the analysis 
plan, no tests for interaction were done because there 
was no evidence of main eﬀ ects for the primary outcome. 
There was only one statistically signiﬁ cant diﬀ erence 
in one component of the primary outcome, which 
was for the intervention pair chromic catgut versus 
polyglactin-910 for uterine repair and the outcome of 
Figure 4: Closure of uterus subgroup analyses
RR=risk ratio.
Timing of caesarean section
Before labour
In labour
Births
Multiple
Singleton
Previous caesarean sections
None
One
Type of anaesthetic 
Regional
General
Surgeons’ experience
<5 years
5–10 years
>10 years
Region
Ghana
India: Delhi
Pakistan
Chile
Sudan 
Favours single layer Favours double layer
pinteractionRR (99% CI)Events (single) Events (double)
0·96 (0·76–1·22)
0·96 (0·78–1·18)
0·88 (0·42–1·84)
0·97 (0·82–1·13)
1·01 (0·83–1·21)
0·87 (0·66–1·15)
0·99 (0·84–1·16)
0·74 (0·43–1·25)
0·92 (0·64–1·31)
0·99 (0·76–1·29)
0·96 (0·76–1·21)
1·08 (0·63–1·85)
1·00 (0·79–1·27)
0·98 (0·75–1·30)
0·85 (0·54–1·34)
0·73 (0·40–1·34)
217/2096
262/2542
19/165
460/4473
338/3181
141/1457
445/4354
34/284
90/1054
165/1626
218/1925
44/634
209/1874
146/981
50/353
30/796
223/2077
276/2570
24/183
475/4464
336/3183
163/1464
450/4346
49/301
99/1064
168/1635
227/1924
41/636
210/1882
149/985
58/347
41/797
0·97
0·74
0·26
0·18
0·91
0·67
1·000·750·50 1·50 2·000·25 3·00
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blood transfusion greater than 1  unit (risk ratio 0·53, 
99% CI 0·30–0·93; table 2). On further assessment, this 
result was robust when adjusted for in-labour versus not 
in-labour caesarean section and suture material used as 
standard in each site (data not shown).
There was no evidence of a diﬀ erence within inter-
vention pairs for any of the other secondary outcomes 
(table 3). For the intervention of blunt versus sharp 
abdominal entry, where the potential diﬀ erence in the 
time taken to enter the abdominal cavity might lead to 
worse neonatal outcomes, there was no evidence of a 
diﬀ erence in the risk of stillbirth or low Apgar score 
(table 4). These ﬁ ndings did not change after allowing for 
clustering for multiple births (table 4).
There was limited consistent and corroborated 
evidence of a diﬀ erential treatment eﬀ ect between the 
subgroups in the eﬀ ect of the interventions on the 
primary outcome (ﬁ gures 2–6). We cannot explain the 
diﬀ erences for Argentina in the comparison of blunt 
versus sharp abdominal entry and for Chile in the 
comparison of chromic catgut versus polyglactin-910 and 
assume that they are spurious associations because of 
the large number of comparisons made. Not all the 
prespeciﬁ ed subgroup analyses were undertaken because 
the size of some of the subgroups was too small. HIV 
infection was present in only 2% of women and intra-
partum fever in only 2% (table 1). The adjusted analyses 
(appendix) and the sensitivity analyses (table 5) resulted 
in no eﬀ ect on the ﬁ ndings for the primary outcome.
144 serious adverse events were reported, of which 
26 were possibly related to the intervention (appendix). 
Most of the reported serious adverse events were known 
complications of surgery or complications of the reasons 
for the caesarean section; for example, obstructed labour 
is a risk factor for post-partum haemorrhage. The intra-
abdominal bleeding and uterine atony that occurred 
might have been because of the surgical techniques being 
used. For example, uterine atony might be caused or 
exacerbated by the method of closure of the uterine 
incision (exteriorisation or intra-abdominal repair), 
single-layer or double-layer closure of the uterus, or the 
use of chromic catgut or polyglactin-910 sutures. The 
appendix shows the distribution of all the serious adverse 
events and those thought to be possibly related to the 
allocated intervention, by randomised intervention pairs. 
There were no statistically signiﬁ cant diﬀ erences in the 
Figure 5: Closure of peritoneum subgroup analyses
RR=risk ratio.
Timing of caesarean section
Before labour
In labour
Births
Multiple
Singleton
Previous caesarean sections
None
One
Type of anaesthetic 
Regional
General
Surgeons’ experience
<5 years
5–10 years
>10 years
Region
Argentina
India: Delhi
India: Vellore
Pakistan
Chile 
Favours closure Favours non-closure
pinteractionRR (99% CI)Events (closure) Events (non-closure)
1·19 (0·96–1·49)
0·95 (0·76–1·19)
0·76 (0·36–1·60)
1·08 (0·92–1·27)
1·20 (0·99–1·46)
0·83 (0·63–1·09)
1·06 (0·90–1·25)
1·07 (0·56–2·05)
1·16 (0·86–1·57)
1·27 (0·96–1·67)
0·87 (0·67–1·12)
1·12 (0·74–1·69)
1·34 (0·99–1·80)
1·00 (0·69–1·44)
0·89 (0·65–1·23)
0·93 (0·61–1·42)
259/2146
237/2676
18/147
478/4675
353/3111
143/1711
468/4631
28/191
146/1597
180/1636
169/1586
76/807
159/1346
88/1047
109/1025
64/597
218/2157
251/2694
23/142
446/4709
294/3119
175/1732
443/4661
26/190
127/1616
142/1635
196/1594
68/809
119/1347
89/1054
123/1033
70/608
0·06
0·23
0·004
0·98
0·02
0·14
1·000·750·50 1·50 2·000·25 3·00
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incidence of serious adverse events. The serious adverse 
events that were possibly related to the allocated 
intervention were 18 haemorrhage (uterine atony or intra-
abdominal bleeding) and six serious infections. The 
serious adverse events included 16 deaths, of which one 
was possibly related to the intervention. This was a death 
due to septicaemia secondary to peritonitis after pre-
sumed intestinal perfora tion. Four deaths were due to 
hypertensive disease; two to aspiration pneumonitis; two 
to obstetric haemor rhage; two to thromboembolic 
disease; one each to renal failure, stroke, brain tumour, 
and H1N1 variant inﬂ uenza; and one unknown cause in a 
woman with hepatitis C.
Discussion
CORONIS was a large randomised trial of caesarean 
section surgical techniques and provides important 
evidence to guide clinical practice (panel). There were no 
statistically signiﬁ cant diﬀ erences within any of the 
intervention pairs for the primary outcome. However, 
there was a statistically signiﬁ cant diﬀ erence in one 
component of the primary outcome: chromic catgut 
versus polyglactin-910 for uterine repair.
This study has limitations. We were unable, for 
practical reasons, to assess all aspects of the caesarean 
section operation that could aﬀ ect maternal morbidity. 
Our choice was based on a consensus meeting of 
investigators who prioritised aspects of the operation as 
being those for which there was little evidence to support 
either approach, or for which there was the potential for 
important short-term or long-term implications, such as 
single-layer versus double-layer uterine closure and 
uterine rupture during a subsequent pregnancy. Com-
pliance was generally very good; however, for mostly 
clinical reasons, surgeons could not always comply with 
the allocated intervention. This might weaken the 
diﬀ erences between randomised groups, but represents 
the pragmatic nature of the trial, thus the ﬁ ndings are 
generalisable. For sites where chromic catgut versus 
polyglactin-910 for uterine repair was one of the assigned 
intervention pairs, surgeons did not always follow the 
trial protocol and used the suture material allocated for 
closing the uterine incision to close other layers 
(appendix). However, adjusting for this non-compliance 
made no diﬀ erence to the risk ratio for the primary 
outcome (appendix).
Figure 6: Uterine repair subgroup analyses
RR=risk ratio.
Timing of caesarean section
Before labour
In labour
Births
Multiple
Singleton
Previous caesarean sections
None
One
Type of anaesthetic 
Regional
General
Surgeons’ experience
<5 years
5–10 years
>10 years
Region
Ghana
India: Vellore
Kenya
Pakistan
Chile
Sudan 
Favours catgut Favours PG-910
pinteractionRR (99% CI)Events (catgut) Events (polyglactin-910)
1·000·750·50 1·50 2·000·25 3·00
0·90 (0·68–1·19)
0·91 (0·71–1·17)
0·87 (0·38–1·97)
0·91 (0·75–1·10)
0·84 (0·67–1·06)
1·04 (0·76–1·44)
0·95 (0·77–1·17)
0·72 (0·46–1·12)
0·76 (0·52–1·11)
0·97 (0·69–1·37)
0·95 (0·72–1·25)
0·84 (0·49–1·45)
0·95 (0·65–1·37)
0·86 (0·54–1·38)
0·98 (0·71–1·35)
0·30 (0·09–0·96)
1·04 (0·57–1·88)
148/1797
186/2797
16/177
318/4417
210/2919
124/1675
281/3932
53/662
75/1180
104/1532
155/1882
39/637
86/1050
52/830
115/1029
6/254
36/794
165/1801
204/2789
20/192
349/4398
251/2927
118/1663
297/3942
72/648
99/1178
107/1530
163/1882
46/633
91/1051
60/827
117/1029
20/251
35/799
0·94
0·89
0·15
0·15
0·37
0·22
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The incidence of the primary outcome was lower than 
anticipated, as was maternal mortality. This ﬁ nding is a 
result of the nature of recruitment of participants to 
randomised controlled trials who are potentially healthier 
than the represented patient population. The pilot study 
(Brocklehurst P, unpublished) assessed outcomes for 
consecutive caesarean sections taking place in several of 
the CORONIS participating sites. By introducing a process 
of enrolment into a trial, women with the greatest risk of 
an adverse outcome are less likely to be recruited; this 
includes women who were to undergo a caesarean section 
in labour but were judged to be unable to provide informed 
consent. This factor might also explain the low maternal 
mortality in this sample of women. Because of the lower 
than expected frequency of the primary outcome, we 
undertook an extensive validation exercise. Validation 
revealed that follow-up personnel were sometimes 
missing important outcomes, such as wound infections. 
Review of source documents and re-interviewing women 
(by independent staﬀ ) identiﬁ ed several unreported 
outcomes; extensive additional training was initiated to 
ensure accurate data capture of these outcomes at the 
postnatal interview for the remainder of the trial.
Despite these potential limitations and the lower than 
anticipated incidence of the primary outcome, this trial 
had suﬃ  cient power to identify modest diﬀ erences in 
short-term outcomes. The only intervention–outcome 
combination for which there was statistical evidence of 
an eﬀ ect was blood transfusion of greater than 1 unit for 
the chromic catgut versus polyglactin-910 compari son. 
When we explored the reasons for the blood transfusion, 
there was an increase in the number of women having a 
blood transfusion for post-partum haemorrhage in the 
polyglactin-910 arm compared with the chromic catgut 
arm. The number of cases was small (36 vs 20), so the 
ﬁ ndings could have arisen by chance. However, there 
is no suggestion, as was widely anticipated, that 
polyglactin-910 was superior to chromic catgut.
CORONIS provides evidence, on the basis of short-
term outcomes, that clinicians can remain free to use 
whichever surgical technique they prefer. Although 
undertaken in low-income and middle-income countries, 
these ﬁ ndings are probably generalisable to other 
settings. The complications of caesarean section are the 
same in all settings, albeit with diﬀ erent frequencies. 
The absence of evidence of a diﬀ erence among any of the 
Abdominal entry Repair of uterus Closure of uterus Closure of peritoneum Uterine repair sutures Total 
(n=15 729)
Blunt 
(n=4619)
Sharp 
(n=4628)
RR 
(95% 
CI)
Exterior 
(n=4899)
Intra-
abdominal 
(n=4896)
RR 
(95% 
CI)
Single 
(n=4639)
Double 
(n=4647)
RR 
(95% 
CI)
Closure 
(n=4824)
Non-
closure 
(n=4851)
RR 
(95% 
CI)
Catgut 
(n=4594) 
PG-910 
(n=4590)
RR 
(95% 
CI)
Primary analysis
Primary 
outcome 
(%) 
439 
(10%)
428
(9%)
1·03 
(0·91–
1·17)
434
(9%)
454
(9%)
0·96 
(0·84–
1·08)
479 
(10%)
499 
(11%)
0·96 
(0·85–
1·08)
496 
(10%)
469 
(10%)
1·06 
(0·94–
1·20)
334
(7%)
369
(8%)
0·90 
(0·78–
1·04)
1467
(9%)
Excluding missing 6-week primary outcome data
Primary 
outcome 
(%)
439/
4520 
(10%)
428/
4531 
(10%)
1·03 
(0·91–
1·17)
434/
4818 
(9%)
454/
4808 
(9%)
0·95 
(0·84–
1·08)
479/
4550 
(11%)
499/
4575 
(11%)
0·97 
(0·86–
1·09)
496/
4726 
(11%)
469/
4747 
(10%)
1·06 
(0·94–
1·20)
334/
4556 
(7%)
369/
4555 
(8%)
0·90 
(0·78–
1·04)
1467/
15 462* 
(10%)
Excluding women assessed after 12 weeks
Primary 
outcome 
(%)
392/
4227 
(9%)
380/
4224 
(9%)
1·03 
(0·90–
1·18)
380/
4388 
(9%)
404/
4354 
(9%)
0·93 
(0·82–
1·07)
443/
4270 
(10%)
457/
4280 
(11%)
0·97 
(0·86–
1·10)
444/
4391 
(10%)
430/
4388 
(10%)
1·03 
(0·91–
1·17)
316/
4364 
(7%)
353/
4371 
(8%)
0·90 
(0·77–
1·04)
1333/
14 419 
(9%)
Subgroup analysis by time to 6-week assessment
Assessment done at ≤6 weeks
Primary 
outcome 
(%) 
42/
446
(9%)
37/
393
(9%)
1·00 
(0·66–
1·52)
38/
441
(9%)
53/
418
(13%)
0·68 
(0·46–
1·01)
50/
422
(12%)
42/
419
(10%)
1·18 
(0·80–
1·74)
33/
414
(8%)
51/
480
(11%)
0·75 
(0·49–
1·14)
19/
200
(10%)
16/
225
(7%)
1·34 
(0·71–
2·53)
127/
1286
(10%)
Assessment done at >6 weeks
Primary 
outcome 
(%)
384/
4056
(10%)
380/
4115
(9%)
1·03 
(0·90–
1·17)
388/
4359
(9%)
393/
4370
(9%)
0·99 
(0·87–
1·13)
421/
4115
(10%)
449/
4142
(11%)
0·94 
(0·83–
1·07)
461/
4310
(11%)
416/
4266
(10%)
1·10 
(0·97–
1·24)
308/
4335
(7%)
345/
4310
(8%)
0·89 
(0·77–
1·03)
1315/
14 126
(9%)
The primary outcome of death or maternal infectious morbidity or further operative procedures or blood transfusion (>1 unit of whole blood and packed cells only) was analysed by time to follow-up after 
delivery. Maternal infectious morbidity deﬁ ned as one or more of the following: antibiotic use for maternal febrile morbidity during post-partum stay (fever on at least two occasions); antibiotic use for 
endometritis, wound infection, or peritonitis up to 6 weeks post partum. Includes any operative procedures on caesarean wound, curettage, laparotomy, artery ligation, brace suture, and hysterectomy. Excludes 
women randomised in error, women who withdrew consent, data not received, and vaginal deliveries (n=206 [1%]). A woman can have more than one component but is included only once in the primary 
outcome. p values were 0·91 for abdominal entry, 0·08 for repair of uterus, 0·28 for closure of uterus, 0·09 for closure of peritoneum, and 0·22 for uterine repair sutures. RR=risk ratio. PG-910=polyglactin-910. 
*Number presented in ﬁ gure 1 does not exclude women randomised in error, women who withdrew consent, data not received, and vaginal deliveries. Primary outcome data are not treated as missing if a 
primary outcome event is recorded on the post-partum form (ie, before the 6 weeks after delivery form). 
Table 5: Sensitivity analyses of the primary outcome 
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Panel: Research in context
Systematic review
There are systematic reviews (including Cochrane reviews) for 
all the intervention pairs included in the CORONIS trial. For the 
comparison of sharp versus blunt abdominal entry at 
caesarean section, a Cochrane review was published in 2008.6 
This review included 11 randomised controlled trials (with a 
total of 1740 women) that compared diﬀ erent approaches to 
abdominal entry, which are comparable to the comparison 
blunt versus sharp abdominal entry in the CORONIS trial 
(described as Joel-Cohen based versus Pfannenstiel). The 
ﬁ ndings from this review suggested that the blunt approach 
to abdominal entry led to less blood loss, a shorter duration of 
surgery (including a shorter duration from skin incision to 
delivery of the baby), and less postoperative fever and pain. 
More serious complications, including blood transfusion of 
the mother, were too few to analyse. The main challenge of 
interpreting these eponymous techniques is that, if done as 
intended, they include prescribed techniques for uterine 
incision closure and abdominal wound closure,15 making 
interpretation of outcomes in relation solely to the method of 
abdominal entry diﬃ  cult.
Exteriorisation of the uterus for repair versus intra-abdominal 
repair was the topic of a systematic review published in 2009, 
which included 11 trials with 3183 women in total .16 The 
investigators found no evidence that one approach was 
superior to the other for several outcomes such as 
intraoperative or postoperative complications including 
endometritis, pain, and nausea and vomiting. There were no 
diﬀ erences in the duration of the operation or in the duration 
of hospital stay. Since this study was published, a trial of 
4925 women has been published.17 This trial found an excess 
of uterine atony in the exteriorisation group (9·1% vs 3·8% in 
the intra-abdominal repair group), although there was no 
statistically significant difference in the incidence of blood 
transfusion. The intra-abdominal repair group had a shorter 
operating time and less postoperative pain and a lower 
incidence of wound infection (4·6% vs 11·5% in the 
exteriorisation group). This ﬁ nding is in contrast to the 
CORONIS trial, which found no diﬀ erences in these outcomes 
in 9795 women.
A Cochrane review of closure versus non-closure of the 
peritoneum (visceral or parietal or both) was last updated in 
2008.18 It incorporated 14 trials including 2908 women and 
found that non-closure reduced operating time, 
postoperative fever, use of pain relief, and hospital stay. 
Since this review was published, a further ﬁ ve trials have 
been published.9,19–22 Four of these trials are moderate in size 
(between 80 and 340 women per trial),19–22 whereas the 
CAESAR trial included 2995 women in this comparison.9 
Some of the smaller trials found similar ﬁ ndings to the 
Cochrane review, with shorter operating times and less 
postoperative febrile morbidity in the non-closure group. 
However, the CAESAR trial found no diﬀ erences in any 
outcomes of postoperative morbidity but did suggest that 
non-closure of the pelvic peritoneum shortened the duration 
of the operation by a mean of 2·3 min. In CORONIS, by 
contrast, we found no diﬀ erence in duration of surgery. 
A Cochrane systematic review of surgical techniques involving 
the uterus at the time of caesarean section included trials of 
single-layer versus double-layer closure of the uterine incision 
(ten trials with 2531 women in total).23 Two further trials that 
compared single-layer and double-layer uterine closure 
published since the Cochrane review was last updated have 
been identiﬁ ed, involving 208 women in one24 and 
2979 women in the other.9 None of the existing studies 
suggest major diﬀ erences in short-term outcomes between 
single-layer and double-layer uterine closure. There was a 
suggestion that single-layer closure might result in a 
decreased estimated blood loss at the time of caesarean 
section and shorter duration of the operative procedure, but 
the addition of the data from the large CAESAR trial suggests 
no diﬀ erences in any of these outcomes. CORONIS, when 
added to the existing evidence, conﬁ rms this absence of 
short-term diﬀ erences in maternal morbidity.
There are no published or ongoing trials comparing 
diﬀ erent suture materials for this element of the caesarean 
section operation.
Interpretation
The published trials of caesarean section surgical techniques are 
mostly small and inconclusive, and pooled estimates show, for 
some of the outcomes, substantial heterogeneity. With respect 
to the ﬁ ve pairs of interventions included in CORONIS, all the 
available evidence suggests that blunt abdominal entry is 
unlikely to oﬀ er any short-term beneﬁ ts for postoperative 
morbidity; non-closure of the peritoneum might decrease the 
duration of the operation by a small amount, but this does not 
translate into improvements in morbidity outcomes; 
single-layer closure of the uterine incision does not improve 
short-term morbidity outcomes; and the use of chromic catgut 
might have moderate advantages over the use of 
polyglactin-910. With respect to whether intra-abdominal 
repair of the uterine incision improves outcome, the available 
evidence is still uncertain. We found no evidence of improved 
outcomes for women in this comparison pair, in contrast to the 
ﬁ ndings by Doganay and colleagues.17
The ﬁ ndings of CORONIS, when combined with the existing 
evidence, suggest that clinicians are free to carry on with their 
existing practices, at least with respect to their eﬀ ect on 
short-term postoperative morbidity. However, particularly for 
interventions that involve closure of the uterine incision 
(single-layer versus double-layer closure or use of diﬀ erent 
suture materials) as well as closure or non-closure of the 
peritoneum, longer-term outcomes are needed to enable 
clinicians to make fully informed decisions about what surgical 
approaches to take. 
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A Hashim, M Khatim, S Mohamed, A Yousif.
*D Okoti died in March, 2008.
CORONIS Collaborative Group investigators (number of women shown in 
parentheses): Argentina (1641) C A Arias, L M Bosquiazzo, J A Bruna, 
M C Fábrica, C Mascotti (Hospital Dr José María Cullen, Santa Fe); 
M S Bertin, J L Castaldi, S J Mendoza, L Y Partida, A Zyla (Hospital 
Interzonal General de Agudos Dr José Penna, Bahía Blanca); L Castilla, 
E Di Gerolano, M Espinoza, G Koch, M Tulían (Hospital J B Iturraspe, 
Santa Fe); M Melis, M Miriam, M Palermo, J Pappalardo, M Quiñones 
(Hospital Nacional Profesor Alejandro Posadas, Buenos Aires); F Cabrera, 
S Campos, M A Curioni, J Fernandez, C Grasselli (Hospital Regional 
Dr Ramón Carrillo, Santiago del Estero); Chile (1237) F Abarzua, G Araya, 
M Caro, C Gonzalez, C Vera (Pontiﬁ cia Universidad Católica de Chile 
Hospital, Santiago); M Araneda, S De La Cuadra, J P Kusanovic, J A Ortiz, 
K Silva (Sotero Del Rio Hospital, Santiago); Ghana (1279) W K Bofa, 
R M Djokoto, T O Konney, Y O Larbi, E Quashie (Komfo Anokye Teaching 
Hospital, Kumasi); India—Delhi (3833) A Kriplani, S Kumar, S Mittal 
(All India Institute of Medical Sciences [AIIMS], Ansari Nagar); U Gupta, 
M Puri, C Raghunandan, S S Trivedi (Lady Hardinge Medical College & 
Sucheta Kriplani Hospital, New Delhi); S Batra, A Kumar, U Manaktala, 
S Prasad (Maulana Azad Medical College & Lok Nayak Hospital, New 
Delhi); N Goel, K Guleria, G Radhakrishnan, A Suneja, N B Vaid 
(University College of Medical Sciences & GTB Hospital, Shahdara); 
India—Vellore (2111) M Beck, A D’Souza, A Sebastian, A E Thomas, 
E Thomas, R Vijayaselvi (Christian Medical College Hospital, Vellore); 
Kenya (1684) F Butt, S Kaliti, E O Nyaboga, M J Owiti, A Wameyo 
(University of Nairobi, Kenyatta National Hospital, Nairobi); Pakistan 
(2554) S Akram, A Junejo, J Khatoon, S Siddiqui, S Zafar (Countess of 
Duﬀ erin Hospital, Hyderabad); F Abbasi, S Aijaz, A Firdous, A Khuwaja, 
B Zulﬁ qar (Fatima Bai Hospital, Karachi); S Batool, H Hashmi, 
S Hussaini, Z Naqvi, S Tahir (Liaquat National Hospital, Karachi); Sudan 
(1605) S Ibrahim, S E Khalil, A Kuna, M Saboni, M Salman (Omdurman 
Maternity Hospital, Omdurman); M S Abubakar, M Awad, M Elbashir, 
N Gaﬀ ar, S Hussain (Soba University Hospital, Khartoum).
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